REFERENCES
- Merritt HH, Putnam TJ: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. JAMA 111:1068, 1938
- Coope R, Burrows RG: Treatment of epilepsy with sodium diphenyl hydantoinate. Lancet 1:490, 1940
- Mandelbaum H, Kane LJ: Dilantin sodium poisoning: Report of a case with dermatitis exfoliativa, pyrexia and hepatic and splenic enlargement. Arch Neurol 45:769, 1941
- Ritchie EB, Kolb W: Reaction to sodium diphenyl hydantoinate: Hemorrhagic erythema multiforme terminating fatally. Arch Dermatol 46:856, 1942
- Van Wyk JJ, Hoffmann CR: Periarteritis nodosa: A case of fatal exfoliative dermatitis resulting from “Dilantin sodium” sensitization. Arch Intern Med 81:605, 1948
- Chaiken BH, Goldberg BI, Segal JP: Dilantin sensitivity: Report of case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 242:897, 1950
- Dubois EL: Toxic hepatic necrosis associated with taking Dilantin, tridione, and phenobarbital: Report of case. Am J Clin Pathol 20:153, 1950
- Gropper AL: Diphenylhydantoin sensitivity: Report of fatal case with hepatitis and exfoliative dermatitis. N Engl J Med 254:522, 1956
- Saltzstein SL, Ackerman LV: Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer 12:164, 1959
- Rosenfeld S, Swiller AI, Shenoy YM, et al: Syndrome simulating lymphosarcoma induced by diphenylhydantoin sodium. JAMA 176:491, 1961
- Siegal S, Berkowitz J: Diphenylhydantoin (Dilantin) hypersensitivity with infectious mononucleosis-like syndrome and jaundice. J Allergy Clin Immunol 32:447, 1961
- Bajoghli M: Generalized lymphadenopathy and hepatosplenomegaly induced by diphenylhydantoin. Pediatrics 28:943, 1961
- Crawford SE, Jones CK: Fatal liver necrosis and diphenylhydantoin sensitivity Pediatrics 30:595, 1962
- Holland P, Mauer AM: Diphenylhydantoin-induced hypersensitivity reaction. J Pediatr 66:322–332, Feb 1965
- Duma RJ, Hendry CN, Donahoo JS: Hypersensitivity to diphenylhydantoin (Dilantin): A case report with toxic hepatitis. South Med J 59:168, 1966
- Harinasula U, Zimmerman HJ: Diphenylhydantoin sodium hepatitis. JAMA 203:1015, 1968
- Lindall AW: The multiple system effects of diphenylhydantoin (Dilantin). Minn Med 52:337, 1969
- Pezzimenti JF, Hahn AL: Anicteric hepatitis induced by diphenylhydantoin. Arch Intern Med 125: 118, 1970
- Ch'ien LT, Ceballos R, Benton JW Jr: Diphenylhydantoin fatal hepatic necrosis (a review of literature and report of a case created with exchange transfusion). Ala J Med Sci 7:318, 1970
- Sparberg M: Diagnostically confusing complications of diphenylhydantoin therapy: A review. Ann Intern Med 59:914, 1963
- Tichner JB, Enselberg CD: Suicidal Dilantin (sodium diphenylhydantoin) poisoning. Case report. N Engl J Med 245:723, 1951
- Boston Collaborative Drug Surveillance Program: Diphenylhydantoin side effects and serum albumin levels. Clin Pharmacol Ther 14:529, 1973